Results:
The baseline characteristics of the patients, that is, characteristics
of the patients before their pregnancies were confirmed, are shown in
Table 1. Baseline characteristics included PTSD history as well as age,
BMI and location . All of these women were taking Prazosin for PTSD in
the beginning of their pregnancy, 6/11 continued Prazosin use during pregnancy after finding out they were pregnant and the remainder (5/11) discontinued prazosin
during the first trimester after they found out they were pregnant. Dose
information on Prazosin was not available. Their mean age (in years) was
33.1 with a standard deviation (SD) of 6.62. Mean BMI (kg/ m^2) was
32.3 with a SD of 5.44. Nine of the 11 patients (81.8%) came from an
urban location, and 2/11(18.2%) of the patients came from a rural
location.